Wasatch Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$337M Sell
636,595
-137,336
-18% -$63.4M 2.21% 5
2026
Q1
$372M Buy
773,931
+125,625
+19% +$64.3M 2.47% 4
2025
Q4
$364M Sell
648,306
-277,657
-30% -$158M 2.16% 8
2025
Q3
$476M Sell
925,963
-19,851
-2% -$8.67M 2.56% 7
2025
Q2
$297M Buy
945,814
+116,354
+14% +$34.9M 1.55% 16
2025
Q1
$253M Sell
829,460
-107,382
-11% -$36.1M 1.41% 18
2024
Q4
$311M Buy
936,842
+28,161
+3% +$9.55M 1.54% 15
2024
Q3
$303M Sell
908,681
-58,602
-6% -$22.3M 1.49% 16
2024
Q2
$398M Sell
967,283
-7,132
-0.7% -$2.82M 2.13% 7
2024
Q1
$394M Sell
974,415
-211,766
-18% -$74.5M 2.06% 7
2023
Q4
$364M Sell
1,186,181
-85,655
-7% -$23.1M 2% 8
2023
Q3
$308M Sell
1,271,836
-297,065
-19% -$76M 1.95% 8
2023
Q2
$377M Sell
1,568,901
-289,753
-16% -$60.2M 2.28% 5
2023
Q1
$350M Buy
1,858,654
+220,836
+13% +$45.7M 2.18% 7
2022
Q4
$348M Sell
1,637,818
-517,688
-24% -$103M 2.34% 5
2022
Q3
$339M Sell
2,155,506
-217,717
-9% -$34.7M 2.35% 7
2022
Q2
$355M Sell
2,373,223
-355,169
-13% -$51.4M 2.25% 6
2022
Q1
$446M Buy
2,728,392
+294,103
+12% +$48.5M 2.2% 6
2021
Q4
$530M Sell
2,434,289
-61,773
-2% -$12.9M 2.16% 3
2021
Q3
$472M Buy
2,496,062
+46,770
+2% +$8.53M 1.92% 6
2021
Q2
$433M Sell
2,449,292
-204,694
-8% -$35.3M 1.76% 8
2021
Q1
$435M Sell
2,653,986
-187,008
-7% -$28.6M 1.96% 4
2020
Q4
$395M Buy
2,840,994
+570,266
+25% +$71.9M 1.95% 7
2020
Q3
$254M Sell
2,270,728
-290,275
-11% -$33.6M 1.61% 12
2020
Q2
$238M Buy
2,561,003
+270,621
+12% +$23M 1.72% 13
2020
Q1
$168M Buy
2,290,382
+485,397
+27% +$42.1M 1.75% 15
2019
Q4
$152M Buy
1,804,985
+398,775
+28% +$30.9M 1.24% 26
2019
Q3
$118M Sell
1,406,210
-598,917
-30% -$45.3M 1.13% 31
2019
Q2
$131M Buy
2,005,127
+600,686
+43% +$34.6M 1.28% 23
2019
Q1
$82.8M Buy
1,404,441
+209,449
+18% +$12.5M 0.9% 45
2018
Q4
$63.3M Buy
+1,194,992
New +$65.6M 0.84% 43

Other funds holding MEDP

Wasatch Advisors's MEDP Position: Q2 2026 in Review

Wasatch Advisors reduced its Medpace (MEDP) stake by 18% in Q2 2026, selling an estimated $63.4M and leaving 636,595 shares worth $337M. The position accounts for 2.21% of the portfolio, ranked #5.

Wasatch Advisors first reported a position in MEDP in Q4 2018 and has held it in 31 quarters since. The position peaked at $530M in Q4 2021. 73 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Wasatch Advisors held 636,595 shares of Medpace worth $337M as of Q2 2026.
  • Wasatch Advisors sold 137,336 Medpace shares in Q2 2026, an estimated $63.4M.
  • Medpace made up 2.21% of Wasatch Advisors's portfolio in Q2 2026, its #5 holding.
  • Wasatch Advisors first reported a position in Medpace in Q4 2018 and has held it in 31 quarters since.
  • Wasatch Advisors's Medpace position peaked at $530M in Q4 2021.
  • 73 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Wasatch Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.